Three-biomarker combo may better predict kidney failure

Researchers at the San Francisco VA Medical Center think they have found a better way to predict risk of kidney failure and death with a combined use of three biomarkers. Currently, chronic kidney disease (CKD) is predicted using certain levels of creatinine-based estimated glomerular filtration rate (GFR), but that often results in a misdiagnosis because, due to several reasons, serum creatinine may misclassify some patients. The author, Carmen A. Peralta, suggests adding albumin-to-creatinine ratio (ACR) and cystatin C to biomarkers, creating a triple threat against kidney failure--at least, when it comes to early prediction. "Our findings illustrate the potential implications of universal screening for CKD using a triple-marker approach," the researchers write. More here

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.